Medicare Part D Drug Plan Costs Half Of Original Estimate

The Congressional Budget Office (CBO) has released a report on the remarkable budgetary achievement of the Medicare Part D prescription-drug benefit:

A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program — about 50 percent lower in 2013 — than CBO projected when the MMA became law in 2003.

Read the entire column at the National Center for Policy Analysis Health Policy Blog.